NEKTAR THERAPEUTICS shareholders Q3 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
MACQUARIE GROUP LTD 256,385$153,0000.00%
Cambridge Investment Research Advisors, Inc. 134,685$800.00%
Citadel Advisors 8,100$4,8240.00%
Citadel Advisors 46,800$27,8740.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 140,439$83,6450.00%
HighTower Advisors, LLC 19,743$11,0000.00%
SIMPLEX TRADING, LLC 10,625$60.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 288,634$171,9100.00%
Global Retirement Partners, LLC 16$80.00%
BLAIR WILLIAM & CO/IL 38,042$22,6580.00%
FRANKLIN RESOURCES INC 34,781$20,7160.00%
HUNTINGTON NATIONAL BANK 1$10.00%
Parallel Advisors, LLC 15,820$9,4220.00%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 61,886$370.00%
WELLS FARGO & COMPANY/MN 5,177$3,0840.00%
FARMERS & MERCHANTS INVESTMENTS INC 113$670.00%
MILLENNIUM MANAGEMENT LLC 1,190,563$709,0990.00%
CITIGROUP INC 77,978$46,4430.00%
MERCER GLOBAL ADVISORS INC /ADV 17,054$100.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.